Literature DB >> 16844922

Role of AMP-activated protein kinase in healthy and diseased hearts.

Vernon W Dolinsky1, Jason R B Dyck.   

Abstract

The heart is capable of utilizing a variety of substrates to produce the necessary ATP for cardiac function. AMP-activated protein kinase (AMPK) has emerged as a key regulator of cellular energy homeostasis and coordinates multiple catabolic and anabolic pathways in the heart. During times of acute metabolic stresses, cardiac AMPK activation seems to be primarily involved in increasing energy-generating pathways to maintain or restore intracellular ATP levels. In acute situations such as mild ischemia or short durations of severe ischemia, activation of cardiac AMPK appears to be necessary for cardiac myocyte function and survival by stimulating ATP generation via increased glycolysis and accelerated fatty acid oxidation. Whereas AMPK activation may be essential for adaptation of cardiac energy metabolism to acute and/or minor metabolic stresses, it is unknown whether AMPK activation becomes maladaptive in certain chronic disease states and/or extreme energetic stresses. However, alterations in cardiac AMPK activity are associated with a number of cardiovascular-related diseases such as pathological cardiac hypertrophy, myocardial ischemia, glycogen storage cardiomyopathy, and Wolff-Parkinson-White syndrome, suggesting the possibility of a maladaptive role. Although the precise role AMPK plays in the diseased heart is still in question, it is clear that AMPK is a major regulator of cardiac energy metabolism. The consequences of alterations in AMPK activity and subsequent cardiac energy metabolism in the healthy and the diseased heart will be discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16844922     DOI: 10.1152/ajpheart.00329.2006

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  52 in total

1.  Resveratrol prevents pathological but not physiological cardiac hypertrophy.

Authors:  Vernon W Dolinsky; Carrie-Lynn M Soltys; Kyle J Rogan; Anita Y M Chan; Jeevan Nagendran; Shaohua Wang; Jason R B Dyck
Journal:  J Mol Med (Berl)       Date:  2014-11-15       Impact factor: 4.599

Review 2.  Age-related cardiovascular disease and the beneficial effects of calorie restriction.

Authors:  Miranda M Y Sung; Jason R B Dyck
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

3.  Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase.

Authors:  Jaroslaw W Zmijewski; Sami Banerjee; Hongbeom Bae; Arnaud Friggeri; Eduardo R Lazarowski; Edward Abraham
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

Review 4.  Recycle or die: the role of autophagy in cardioprotection.

Authors:  Asa B Gustafsson; Roberta A Gottlieb
Journal:  J Mol Cell Cardiol       Date:  2008-02-13       Impact factor: 5.000

5.  Targeting skeletal muscle AMP-activated protein kinase to treat type 2 diabetes.

Authors:  Eric B Taylor; Laurie J Goodyear
Journal:  Curr Diab Rep       Date:  2007-12       Impact factor: 4.810

Review 6.  Regulation of AMPK by the ubiquitin proteasome system.

Authors:  Makhosazane Zungu; Jonathan C Schisler; M Faadiel Essop; Chris McCudden; Cam Patterson; Monte S Willis
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

7.  Resveratrol protects ROS-induced cell death by activating AMPK in H9c2 cardiac muscle cells.

Authors:  Jin-Taek Hwang; Dae Young Kwon; Ock Jin Park; Myung Sunny Kim
Journal:  Genes Nutr       Date:  2008-02       Impact factor: 5.523

8.  TXNIP regulates myocardial fatty acid oxidation via miR-33a signaling.

Authors:  Junqin Chen; Martin E Young; John C Chatham; David K Crossman; Louis J Dell'Italia; Anath Shalev
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-03       Impact factor: 4.733

9.  AMP-activated protein kinase deficiency enhances myocardial ischemia/reperfusion injury but has minimal effect on the antioxidant/antinitrative protection of adiponectin.

Authors:  Yajing Wang; Erhe Gao; Ling Tao; Wayne Bond Lau; Yuexin Yuan; Barry J Goldstein; Bernard L Lopez; Theodore A Christopher; Rong Tian; Walter Koch; Xin-Liang Ma
Journal:  Circulation       Date:  2009-02-02       Impact factor: 29.690

10.  Stimulation of Brain AMP-Activated Protein Kinase Attenuates Inflammation and Acute Lung Injury in Sepsis.

Authors:  Nikhil Mulchandani; Weng-Lang Yang; Mohammad Moshahid Khan; Fangming Zhang; Philippe Marambaud; Jeffrey Nicastro; Gene F Coppa; Ping Wang
Journal:  Mol Med       Date:  2015-07-30       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.